CHOP-mediated hepcidin suppression modulates hepatic iron load.

Area of Science:

• Hepatology
• Iron Metabolism
• Molecular Biology

Background:

• Chronic liver diseases often result in systemic iron overload.
• Hepcidin, a key iron-regulatory hormone, shows diminished expression in these conditions.
• The precise regulation of iron metabolism during hepatic disease remains incompletely understood.

Purpose of the Study:

• To investigate the role of CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CHOP) in regulating hepcidin expression in chronic liver disease models.
• To elucidate the mechanisms underlying iron dysregulation in response to liver injury.

Main Methods:

• Utilized two established models of chronic liver injury: repeated carbon tetrachloride (CCl(4)) and thioacetamide (TAA) injections in mice.
• Assessed hepcidin and CHOP expression in wild-type and CHOP knockout mice following TAA administration.
• Analyzed CHOP and hepcidin expression in human subjects with and without alcoholic liver disease.

Main Results:

• Both CCl(4) and TAA models exhibited macrophage iron overload; TAA also caused hepatocyte iron accumulation.
• TAA-induced liver injury led to significant hepatic and systemic iron overload, correlated with suppressed hepcidin levels.
• CCAAT/enhancer-binding protein alpha (C/EBPα) signaling, a hepcidin inducer, was inhibited in TAA mice due to reduced C/EBPα and increased CHOP, a C/EBPα inhibitor.
• Acute TAA administration caused prolonged hepcidin suppression, which was attenuated in CHOP knockout mice.
• Alcoholic liver disease patients showed significantly elevated CHOP mRNA levels that negatively correlated with hepcidin expression.

Conclusions:

• CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CHOP) is identified as a key regulator of hepatic hepcidin expression in the context of chronic liver disease.
• CHOP contributes to iron overload by suppressing hepcidin in liver injury.
• Differential regulation of hepcidin by CHOP may explain variations in iron metabolism observed in different liver disease models.